- In February 2025, Boston Scientific Corporation announced the global launch of its SpyGlass Discover Digital Catheter, a single-use, digital cholangioscope designed for ERCP procedures. This next-generation device enhances image clarity and access to difficult ductal areas, improving diagnostic and therapeutic accuracy for biliary and pancreatic disorders. The launch represents Boston Scientific’s continued focus on advancing minimally invasive endoscopic technology
- In January 2025, Olympus Corporation introduced its EVIS X1 Duodenoscope, featuring advanced imaging capabilities and improved ergonomics to support complex ERCP interventions. This innovation aims to reduce infection risks and elevate procedural efficiency, aligning with global trends toward device sterilization and single-use components
- In December 2024, Medtronic plc revealed plans to expand its ERCP product portfolio by investing in the development of robot-assisted endoscopic platforms. The company is working toward integrating AI-driven navigation for real-time imaging during ERCP procedures, highlighting its commitment to precision and automation in endoscopy
- In October 2024, FUJIFILM Holdings Corporation launched a strategic collaboration with several European hospitals to conduct clinical trials of its new ELUXEO Lite ERCP System, which includes multi-light imaging for improved visualization of bile duct lesions. The project emphasizes FUJIFILM’s push to capture more market share in Europe by offering physician-friendly tools for complex endoscopic procedures
- In September 2024, Ambu A/S gained FDA clearance for its Ambu aScope Duodeno, a single-use duodenoscope designed to eliminate cross-contamination risks associated with reusable scopes. The approval is a significant milestone in the U.S. ERCP devices space, supporting hospitals in complying with stringent infection control standards
